Latest Issue

It’s good to share

A new plan to give away trade secrets could improve big pharma's awful reputation

By Jim Giles   April 2009

Critics loved the Oscar-winning film The Constant Gardener. But it must have been greeted with dismay in the boardrooms of big pharmaceutical companies when it was released in 2005: the film shows them ruthlessly willing to swap lives for profits. And it was just one of many low points for the industry in the last decade. At times it seemed as if its mission was to manufacture public relations disasters, not drugs. In 1998, big pharma took on Nelson Mandela’s plan to make Aids treatments affordable. (It lost). As if going up against the world’s most respected man wasn’t enough,…

Register today to continue reading

You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.

You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.

Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.

Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We want to hear what you think about this article. Submit a letter to

More From Prospect